M. Wirth

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.

A. Garnham, R. Garzonio, T. Visakorpi, 2022, Clinical genitourinary cancer.

Introducing PIONEER: a project to harness big data in prostate cancer research

Delila Gasi Tandefelt, C. Auffray, H. Huisman, 2020, Nature Reviews Urology.

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)

S. Löck, M. Krause, D. Zips, 2022, Cancers.

Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.

S. Löck, M. Krause, D. Zips, 2021, European urology oncology.

Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer

S. Füssel, G. Baretton, Sven-Holger Puppel, 2023, BMC Cancer.

Introducing PIONEER: a project to harness big data in prostate cancer 2 research

C. Auffray, D. Lancet, C. Reich, 2019 .

A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer

M. Kreuz, Michael Rade, C. Blumert, 2024, Molecular medicine.